21250 Hawthorne Boulevard, Suite 800
171 articles with DaVita Inc.
Elite Dental Partners has named Gaurav Bhattacharyya as CEO. Bhattacharyya has been President of EDP since July.
Company makes Dow Jones Sustainability Indices for the third time
Cyclists collectively rode more than 90,000 miles through Pennsylvania to raise awareness about kidney disease
DaVita Inc. announced that it will hold its Capital Markets Day in New York City on Tuesday, September 10, 2019, from 8:30 a.m. to 11:30 a.m. Eastern Time.
DAVITA INC. announced the final results of its modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not more than $61.50, which expired at 12:00 midnight, New York City time, at the end of the day on August 16, 2019.
DaVita Kidney Care, celebrated its 2019 sustainability milestones
The total of 21,969,132 shares that the Company expects to accept for repurchase represents approximately 13.7% of the Company's total outstanding shares of common stock as of August 16, 2019.
DAVITA INC. (NYSE: DVA) ( "DaVita" or the "Company"), a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today that it has entered into a new $5.5 billion senior secured credit agreement, dated as of August 12, 2019
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2019.
Dr. Dorothy Fisher and Ian Laird help lead team in providing home-based primary care to the nation's Most Vulnerable Patients (MVPs) [31-July-2019] DENVER , July 31, 2019 /PRNewswire/ -- DaVita Health Solutions today announced two additions to its leadership team: Dr. Dorothy "Dody" Fisher, national medical director, and Ian Laird , national vice president of growt
DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share
DAVITA INC. announced that it has commenced a modified "Dutch auction" tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not greater than $61.50.
DaVita Inc., a leading provider of kidney care services in the United States and in 9 countries around the world, announced that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 1, 2019, at 5:00 p.m. Eastern Time.
DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019
DaVita Inc., announced preliminary second quarter 2019 financial and operating results and updated guidance for fiscal year 2019.
DaVita Kidney Care appreciates President Trump, the Administration and Secretary Azar for taking steps to improve the lives of kidney patients.
Affirms commitment to value-based kidney care and improving kidney disease prevention, home dialysis and transplantation
Company highlights achievements in patient care, community growth and sustainability
DaVita Inc. announced results for the quarter ended March 31, 2019.
Javier J. Rodriguez named CEO effective June 1, 2019; Kent J. Thiry to serve as Executive Chairman of the board of directors
DaVita Inc. announced that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 7, 2019, at 5:00 p.m. Eastern Time.
By 2022, DaVita Inc. (NYSE: DVA) expects to use 100 percent renewable energy.